Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

21 November 2002

Dynamic changes in cellular immune responses in experimental bovine tuberculosis.

Siddhartha N. Joardar, Gulab C. Ram, Tapas K. Goswami

Med Sci Monit 2002; 8(11): BR471-480 :: ID: 4843


BACKGROUND: The development of T-cell responses in natural hosts, such as cattle, would be a useful model of tuberculosis to investigate the changing pattern of T-cell responses and mycobacterial antigens recognized along with the progression of the disease. MATERIAL/METHODS: The present study was undertaken to characterize immune-effector cells and cytokines in Mycobacterium bovis AN5-sensitized cattle, from day 0 to 45 weeks post inoculation (PI). In vitro lymphoproliferation, cytotoxic T lymphocyte (CTL) response, and cytokine release pattern (viz. IL-2, IFN-gamma) from activated PBMC were assessed throughout the spectrum. The effort was made to identify various T-cell target antigens during different post sensitization stages, using T-cell immunoblotting. RESULTS: Cell-mediated immune (CMI) responses were very high between the 9th and 20th week PI. The early appearance of gd+ T-cells was followed by the predominance of CD4+ T-cells, and finally CD8+ T-cells until the 20th week PI. Lymphocyte-effector activity in terms of lymphoproliferation and CTL responses were quite evident between the 9th and 20th weeks PI and around the 12th week PI, respectively. Certain immunodominant polypeptides of culture filtrate preparation of molecular weights 72-74, 30-32, 25 & 22-24 kDa induced higher lymphoproliferation and CTL responses. The kinetics of in vitro cytokine release (IL-2 and IFN-gamma) from PBMC showed a definite trend in all M. bovis AN5-sensitized cattle, with a high concentration between the 9th and 20th weeks PI. CONCLUSIONS: The present investigation revealed some basic aspects of the immune-effector mechanism pertaining to bovine tuberculosis.

Keywords: Mycobacterium bovis - metabolism, Tuberculosis, Bovine - immunology, Tuberculosis, Bovine - microbiology

Add Comment 0 Comments


01 June 2024 : Editorial  

Editorial: Concerns as Highly Pathogenic Avian Influenza (HPAI) Virus of the H5N1 Subtype is Identified in Dairy Cows and Other Mammals

Dinah V. Parums

DOI: 10.12659/MSM.945315

Med Sci Monit 2024; 30:e945315


In Press

Clinical Research  

Impact of COVID-19-Induced Academic Stress on Insomnia and Suicidal Ideation among Taiwanese Health Trainee...

Med Sci Monit In Press; DOI: 10.12659/MSM.944932  

Review article  

Impact of Workplace Bullying on Nursing Care Quality: A Comprehensive Review

Med Sci Monit In Press; DOI: 10.12659/MSM.944815  

Clinical Research  

Anterior Plate-Supported Cannulated Screw Surgery for Ankle Arthrodesis: Clinical and Radiologic Results in...

Med Sci Monit In Press; DOI: 10.12659/MSM.944452  

Clinical Research  

Elevated Plasma Levels of Growth Arrest Specific 6 (Gas6) Protein in Severe Obesity: Implications for Adipo...

Med Sci Monit In Press; DOI: 10.12659/MSM.944462  

Most Viewed Current Articles

17 Jan 2024 : Review article   1,964,783

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research   1,542,370

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research   690,428

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial   50,342

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750